Certified by Founder Lodge
Odyssey Therapeutics
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $101,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 06 ,2023 | Series C | $101,000,000 | |
| September, 12 ,2025 | Series D | $213,000,000.00 |
BlackMars Capital GmbH
OrbiMed
Foresite Capital
Alexandria Real Estate Equities, Inc.
T. Rowe Price
Catalio Capital Management
Walleye Capital
Ascenta Capital
SR One Capital Management
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
